These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 9553430)

  • 1. [Complications of polychemotherapy for renal tuberculosis].
    Kul'chavenia EV; Kuznetsov PV
    Probl Tuberk; 1998; (1):28-30. PubMed ID: 9553430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
    Zierski M; Bek E
    Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
    [No Abstract]   [Full Text] [Related]  

  • 3. Adverse drug reactions observed during DOTS.
    Dhingra VK; Rajpal S; Aggarwal N; Aggarwaln JK; Shadab K; Jain SK
    J Commun Dis; 2004 Dec; 36(4):251-9. PubMed ID: 16506547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tuberculostatics-induced systemic lupus erythematosus].
    Layer P; Engelhard M
    Dtsch Med Wochenschr; 1986 Oct; 111(42):1603-5. PubMed ID: 3769804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of drug-induced hyperuricaemia on renal function in Nigerians with pulmonary tuberculosis.
    Adebisi SA; Oluboyo PO; Okesina AB
    Afr J Med Med Sci; 2000; 29(3-4):297-300. PubMed ID: 11714010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Split-drug regimens for the treatment of patients with sputum smear-positive pulmonary tuberculosis--a unique approach.
    Santha T; Rehman F; Mitchison DA; Sarma GR; Reetha AM; Prabhaker R;
    Trop Med Int Health; 2004 May; 9(5):551-8. PubMed ID: 15117298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone-free antituberculosis treatment in Yaounde, Cameroon.
    Kuaban C; Bercion R; Koula-Shiro S
    Cent Afr J Med; 1998 Feb; 44(2):34-7. PubMed ID: 9675969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Risk factors for the occurrence of eye damage following ethambutol treatment].
    Bastian A; Brandt HP
    Z Erkr Atmungsorgane; 1987; 169(2):162-5. PubMed ID: 3687108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optic neuropathy in ethambutol-treated renal tuberculosis.
    DeVita EG; Miao M; Sadun AA
    J Clin Neuroophthalmol; 1987 Jun; 7(2):77-86. PubMed ID: 2956288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biochemical bases of adverse reactions to antibacterial preparations used in renal tuberculosis and means of their prevention].
    Kazakov KS; Chernik RB; Krivtsova MA
    Probl Tuberk; 1989; (6):52-5. PubMed ID: 2771913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Case of fatal liver failure due to anti-tuberculous therapy].
    Harada Y; Kawakami K; Koyama K; Yamaryo T; Kimura Y
    Kekkaku; 2007 Sep; 82(9):705-9. PubMed ID: 17969987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adverse effects of antitubercular drugs: epidemiology, mechanisms, and patient management].
    Aouam K; Chaabane A; Loussaïef C; Ben Romdhane F; Boughattas NA; Chakroun M
    Med Mal Infect; 2007 May; 37(5):253-61. PubMed ID: 17336011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative anti-tuberculosis regimen including ofloxacin for the treatment of patients with hepatic injury.
    Szklo A; Mello FC; Guerra RL; Dorman SE; Muzy-de-Souza GR; Conde MB
    Int J Tuberc Lung Dis; 2007 Jul; 11(7):775-80. PubMed ID: 17609053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tuberculostatics. General adverse effects].
    Mordasini ER; Eulenberger J
    Int Z Klin Pharmakol Ther Toxikol; 1972 Feb; 5(4):499-518. PubMed ID: 4339952
    [No Abstract]   [Full Text] [Related]  

  • 16. [How to oversee the treatment of tuberculosis?].
    Germouty J; Serizay B; Demonet B; Charles A
    Sem Hop; 1970 Jun; 46(27):1911-4. PubMed ID: 4316120
    [No Abstract]   [Full Text] [Related]  

  • 17. Is pyrazinamide really the third drug of choice in the treatment of tuberculosis?
    Koumbaniou C; Nicopoulos C; Vassiliou M; Manda-Stachouli C; Sakellariou K; Demou GS; Constantopoulos SH
    Int J Tuberc Lung Dis; 1998 Aug; 2(8):675-8. PubMed ID: 9712283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should ethambutol be recommended for routine treatment of tuberculosis in children? A review of the literature.
    Trébucq A
    Int J Tuberc Lung Dis; 1997 Feb; 1(1):12-5. PubMed ID: 9441051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Side effects of antitubercular drugs leading to discontinuation of drug therapy].
    Bergan S; Laake K; Bjartveit K
    Tidsskr Nor Laegeforen; 1980 Feb; 100(5):279-82. PubMed ID: 7385151
    [No Abstract]   [Full Text] [Related]  

  • 20. Adverse reactions to drugs used in the treatment of tuberculosis.
    Nariman S
    Adverse Drug React Acute Poisoning Rev; 1988; 7(4):207-27. PubMed ID: 3071113
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.